Related Experiment Video
Updated: Sep 23, 2026

Multi-color Localization Microscopy of Single Membrane Proteins in Organelles of Live Mammalian Cells
Published on: June 30, 2018
The threat from the pink corner
1Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK. david.livermore@hpa.org.uk
Abstract:
In terms of numbers of isolates, the greatest present resistance problems arise with gram-positive pathogens (which stain purple/black in Gram's method), especially methicillin-resistant Staphylococcus aureus (MRSA). But, is the MRSA problem--by its size--blinding us to something ultimately more dangerous: the slow emergence of gram-negative pathogens (which stain pink) with resistance to all reliable antibiotics? Although presently rare, 'pan-resistant' gram-negative bacteria--predominantly strains of Pseudomonas aeruginosa and Acinetobacter baumannii--have more comprehensive resistance than any gram-positive pathogen. They already pose treatment problems in compromised hospital patients, especially in specialist units, as well in particular groups, such as cystic fibrosis patents. Disturbingly, there is a near-total lack of developmental antibiotics active against gram-negative pathogens.
Insights
While methicillin-resistant Staphylococcus aureus (MRSA) presents current challenges, the slow rise of pan-resistant gram-negative pathogens like Pseudomonas aeruginosa is a more significant future threat. These bacteria exhibit broad resistance, complicating treatment for vulnerable patients.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Gram-positive pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), are currently the primary focus of antibiotic resistance concerns.
- However, the increasing prevalence of pan-resistant gram-negative pathogens poses a potentially greater, yet under-recognized, threat.
Purpose of the Study:
- To highlight the escalating danger of pan-resistant gram-negative bacteria.
- To contrast the current focus on MRSA with the more comprehensive resistance of emerging gram-negative strains.
- To underscore the critical lack of new antibiotic development targeting gram-negative pathogens.
Main Methods:
- Comparative analysis of antibiotic resistance profiles between gram-positive and gram-negative pathogens.
- Review of clinical treatment challenges posed by pan-resistant gram-negative bacteria.
- Assessment of the current antibiotic development pipeline for gram-negative infections.
Main Results:
- Pan-resistant gram-negative bacteria, notably Pseudomonas aeruginosa and Acinetobacter baumannii, demonstrate broader antibiotic resistance than any gram-positive pathogen.
- These resistant gram-negative strains are already causing treatment difficulties in immunocompromised patients, particularly in intensive care and specialized units.
- There is a severe deficit in the development of novel antibiotics effective against these challenging gram-negative pathogens.
Conclusions:
- The emergence of pan-resistant gram-negative bacteria represents a critical and growing threat in healthcare settings.
- The current focus on MRSA may be overshadowing the more profound danger posed by highly resistant gram-negative infections.
- Urgent development of new antimicrobial agents targeting gram-negative pathogens is essential to avert a future public health crisis.
Related Concept Videos
Microtubule Instability
Microtubule Instability
IP3/DAG Signaling Pathway
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Destabilization of Microtubules
